Could this pill delay Parkinson's progression? new trial begins

NCT ID NCT06757010

Completed Symptom relief Sponsor: BioVie Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study tests a drug called bezisterim (NE3107) in 60 people with early Parkinson's disease who have not yet started standard treatment. The goal is to see if it can improve movement symptoms like stiffness and slowness. Participants take the drug or a placebo twice daily for four months, and researchers track changes using a standard rating scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSONS DISEASE (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSONS DISEASE (PD)

Contacts and locations

Locations

Dent Neurologic

Amherst, New York, 14226, United States
NeuroScience Research Center, LLC

Canton, Ohio, 44718, United States
Quest Research Institute

Farmington Hills, Michigan, 48334, United States
Science 37 (Nationwide Site)

Morrisville, North Carolina, 27560, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.